The 2022 report features peer-reviewed studies published in scientific journals, large cancer research grants, immuno-oncology advancements, Pelotonia-funded initiatives, the OSUCCC – James Center for Cancer Engineering, new recruits and some of our far-reaching collaborations during the past calendar year.
Two notable events are highlighted: the OSUCCC – James international scientific symposium held in memory of renowned scientists Drs. Clara D. Bloomfield and Albert de la Chapelle and the retirement of respected surgical oncologist and James CEO William Farrar, MD, after 46 years at Ohio State.
OSUCCC – James researchers in 2022 gained 23 NCI grants that boosted the cancer program’s NCI funding to $64.2 million. They also opened 152 clinical trials, bringing the total number of available cancer clinical trials at Ohio State to nearly 700, and they published 825 articles about their work in peer-reviewed scientific journals. Other key research and clinical facts are noted in a special four-page section of the report.
In addition, the report summarizes key 2022 research and initiatives funded by Pelotonia – the annual cycling event that raises millions of dollars for cancer research at Ohio State – including: the Pelotonia Institute for Immuno-Oncology; the Pelotonia Scholars Program that enables Ohio State students at all levels to conduct cancer research with faculty mentors; the Idea Grants program that provides teams of faculty researchers with seed money to generate early data for innovative research projects; and several statewide initiatives focused on the prevention of colorectal, lung, endometrial (uterine) and breast cancer.
Also within is a profile of the innovative Biofabrication Lab within the OSUCCC – James Center for Cancer Engineering, a look at seven senior-level recruits, and a glimpse at multiple institutional and individual/team achievements, awards and honors that reflect the groundbreaking impact of Ohio State’s cancer program.
Read the 2022 Accomplishments Report to learn more about the many successes and advances that have collectively contributed to the OSUCCC – James’ international acclaim and that help move us closer to a cancer-free world.
View the complete report in PDF format